u/certified_reference

Same experience with the appetite effect being flatter across the week rather than front-loaded.

SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change.

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

Which programme and which readout are you quoting?

Removed — cropped document. Post the whole page or do not post it; the fields people crop are the fields that matter.

On comparing yourself with the trial number.

SURMOUNT-1 reported roughly 21% mean body weight change at 72 weeks on the highest arm. Three things get dropped every time that figure is quoted here. It is a mean, and the distribution around it is very wide. It is 72 weeks, which is a year and a half. And it is a trial population with trial support, which is not the same as a person with a spreadsheet.

Use it as a rough shape, not a benchmark. A 12% year is inside the ordinary range and people quit over it every week on this board.

Left up and flaired Explainer. This is the answer we keep linking, written properly.

Small fix — 214nm, not 280nm. It matters here because the impurity you are asking about barely absorbs at the longer wavelength.

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.

Reminder: a question about a document is not an accusation about a supplier, and posts that blur the two get retitled.

Disagree — that is a weight endpoint from a different programme and you are quoting it in a hepatic context.

a total of 0.4% tells you less than four named impurities adding to 0.6%

Does the lot on the vial match the lot on the page?

Related substances itemised individually is a much stronger document than a single total, because it tells you the shape of the impurity profile rathe

amara_halonen has the distinction right — one is a fraction of the detector signal, the other is a fraction of the mass.

a lot of people plateau nicely at 10mg and never need 15

read the histology endpoint definitions before quoting a response rate

Reminder: a question about a document is not an accusation about a supplier, and posts that blur the two get retitled.

Sent a vial to Janoshik because there was nothing on file. 98.0% against a claimed 97.5%. First entry for this compound in my own log.

Spent four months confusing area% and mass% in every post I made here. One explainer thread and it clicked permanently.

Reminder: a question about a document is not an accusation about a supplier, and posts that blur the two get retitled.

The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.

Cosigning the four-week thing. It is a minimum interval, and treating it as a schedule to keep up with is how people end up miserable at 12.5.

Small fix — 214nm, not 280nm. It matters here because the impurity you are asking about barely absorbs at the longer wavelength.

the lot on the vial has to match the lot on the page

A stability statement is only meaningful with its conditions attached: temperature, duration, light exposure, and whether it covers powder or solution. Ask which.

Push back: you cannot infer degradation from a temperature excursion alone. That is what testing is for.

The PDF creation date being later than the analysis date is usually a re-issue or a re-export. It is worth one question and it is not evidence of anything on its own.

Yes — 10mg being a genuine landing place for a lot of people is underrated. There is no medal for 15.

Removed — cropped document. Post the whole page or do not post it; the fields people crop are the fields that matter.

Your name and address edited out of the screenshot above. The batch details are untouched and should stay.

the lot on the vial has to match the lot on the page

A transit temperature logger records a distribution, and time above a threshold matters as much as peak temperature. That is the argument for logging rather than guessing.

a liver endpoint is not a weight endpoint with better marketing

The escalation schedules in the published protocols are slow and deliberate, and the tolerability tables show why. That is a description of the trials rather than a suggestion for anybody.

regional stock removes most of this problem entirely

Agreed on seasonality. The same lane in February and August is not the same lane.

net peptide content and purity are two different numbers on the same vial